The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
While Canadaand Mexico negotiated monthlong reprieves on Monday, the new tariffs on China went into effect as expected Tuesday, Feb. 4. And while the ultimate shape of Trump’s tariff policy remains to ...
A DGIST research team, led by Professor Kyung-In Jang, has developed a smart patch capable of real-time biometric signal ...
Music has the best chance of providing pain relief when it is played at our natural rhythm, a McGill University research team has discovered. This suggests it may be possible to reduce a patient’s ...
A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...
Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
In a room at Maisonneuve-Rosemont Hospital in Montreal, a patient puts on a virtual reality (VR) headset. Bright bubbles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback